{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:17:30Z","timestamp":1793902650600,"version":"4.8.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133023","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T17:55:41Z","timestamp":1439920541000},"page":"e0133023","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Tianjing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Dickersin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1002\/0470854596","article-title":"Cross-over Trials in Clinical Research","author":"S Senn","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1002\/0471740136","article-title":"Clinical trials: a methodologic perspective","author":"S Piantadosi","year":"2005"},{"issue":"15","key":"ref3","first-page":"276","article-title":"On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications","volume":"109","author":"S Wellek","year":"2012","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/(SICI)1097-0258(19960530)15:10<953::AID-SIM213>3.0.CO;2-M","article-title":"Cross-over trials with censored data","volume":"15","author":"M Feingold","year":"1996","journal-title":"Stat Med"},{"issue":"4","key":"ref5","first-page":"CD003167","article-title":"Medical interventions for primary open angle glaucoma and ocular hypertension","author":"C Vass","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1745-6215-10-27","article-title":"Design, analysis, and presentation of crossover trials","volume":"10","author":"EJ Mills","year":"2009","journal-title":"Trials"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"DR Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/j.1552-4604.1995.tb05016.x","article-title":"Clinical trials in chronic diseases","volume":"35","author":"TJ Cleophas","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/sim.4780081202","article-title":"The performance of the two-stage analysis of two-treatment, two-period crossover trials","volume":"8","author":"PR Freeman","year":"1989","journal-title":"Stat Med"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/sim.4780060504","article-title":"Modelling binary data from a three-period cross-over trial","volume":"6","author":"B Jones","year":"1987","journal-title":"Stat Med"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/sim.4780101012","article-title":"The analysis of categorical data from cross-over trials using a latent variable model","volume":"10","author":"MG Kenward","year":"1991","journal-title":"Stat Med"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2307\/2532242","article-title":"Marginal modeling of binary cross-over data","volume":"49","author":"MP Becker","year":"1993","journal-title":"Biometrics"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/096228029400300403","article-title":"The analysis of binary and categorical data from crossover trials","volume":"3","author":"MG Kenward","year":"1994","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0197-2456(86)90036-X","article-title":"Using baseline measurements in the two-period crossover clinical trial","volume":"7","author":"AR Willan","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"KF Schulz","year":"2010","journal-title":"BMJ"},{"key":"ref16","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"JPT Higgins","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ije\/dym001","article-title":"Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials","volume":"36","author":"DN Lathyris","year":"2007","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archopht.124.11.1553","article-title":"24-Hour control with a latanoprost-timolol fixed combination vs timolol alone","volume":"124","author":"AG Konstas","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3129\/i06-096","article-title":"Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension","volume":"42","author":"P Harasymowycz","year":"2007","journal-title":"Can J Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T11:24:45Z","timestamp":1540293885000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133023"}},"subtitle":[],"editor":[{"given":"Lamberto","family":"Manzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133023","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}